Hyderabad: Bharath Biotech has decided to reduce the price of Covaxin vaccine to R400 from R600 per dose for supply to state governments.
The company announced on Thursday that the price cut has been announced as it is deeply concerned about the critical pandemic in India. Realizing the enormous challenges facing the public health care system, the company decided to make Covaxin available to state governments at a price of Rs 400 per dose.
The company has maintained that it’s transparent in its pricing approach, which is determined by internally funded product development, various industry-intensive BSL-3 manufacturing facilities and clinical trials. The press release shows how Bharat Biotech handled the Sars-CoV-2 virus strains fearlessly and worked tirelessly around the clock, while overcoming many challenges in the uncertainty of the pandemic.
“With most of the organisation’s facilities and resources being diverted there Covid-19 vaccines, w continue to offer superior Covid-19 vaccines and sincerely wish that this gesture would enable our country to recover faster ”, the company’s press release said.
Source: Telangana Today